Wereport a case of recurrent Pindborg tumor (calcifying epithelial odontogenic tumor)of themaxilla. The patient wasa 34-year-old womanwhohad been previously diagnosed with Pindborg tumor and treated with curettage. Shewassubsequently referred tousfor evaluation ofnasal obstruction. Examination revealed thepresence ofa mass lesion in the right nasalcavityand right maxilla, which was identified as a recurrence of her earlier Pindborg tumor. The patient was treated with maxillectomy with orbitalpreservation. Pindborgtumor isa rare odontogenic tumor; when it does occur, it is more often seen in the mandible than in the maxilla. While this tumor is often treated with curettage alone, the aggressive nature of the recurrence in our patient necessitated radical surgery. We report this case to highlight the need to be suitably aggressive in treating these types of tumors in order to avoidrecurrence.
Introduction
Pindborg tumor (calcifying epithelial odontogenic tumor [CEOTj) is named for the Danish pathologist Iens recurrence rate of 10to 15%. 4 Malignant transformation and metastasis are very rare.S These tumors are characterized by the presence of squamous cell proliferation, calcified rings, and amyloid or amyloid-like deposits.'
We report a case of recurrent Pindborg tumor of the maxilla that is interesting in view of its atypical presentation and its aggressive nature, which required a maxillectomy.
Case report
A 34-year-old woman was referred to us for evaluation of a right-sided facial swelling and nasal obstruction of 6 months' duration. She reported no other ENT symptoms. Her history included extraction of her upper molars on the right side 2 years earlier by a dental surgeon in the Department of Oral and Maxillofacial Surgery at the KVG Dental College in Sullia, India. The extraction had been performed to aid the drainage of what was suspected to be a chronic dentoalveolar abscess in the upper alveolus and hard palate on that side. However, a biopsy of the suspected abscess was suggestive of CEOT, and the patient was treated with curettage.
The patient remained asymptomatic for 1 year, but then she developed a gradually progressive right-sided nasal 0 bstruction with some slight swelling over the right cheek. At that point, she was referred to the Department ofENT-Head and NeckSurgeryatthe YenepoyaMedical College in Mangalore, India.
In the ENT clinic, examination revealed the presence of a smooth, mucosa-covered mass in the lateral wall of the right nasal cavity in the area of the inferior and middle meatus. Minimal fullness of the right cheek was also noted. The mass had caused a bulge in the soft palate and gingivobuccal sulcus (figure 1). The mass had partially obliterated the nasal airway, and the nasal septum was pushed to the left side. Findings on a ENT-Ear, Nose & Throat Journal· February 2013 postnasal examination were normal, and no paranasal sinus tenderness was present. Examination confirmed the absence of the right upper molars and premolars as a result of the patient's previous surgery; the oral cavity was otherwise normal.
Computed tomography (CT) identified a 2.5 x 2.5 x 5-cm radiopaque mass lesion that involved the right maxilla and extended from the hard palate inferiorly to the orbital floor superiorly (figures2 and 3).The mass had eroded the medial wall to involve the anterior ethmoid sinuses. It had pushed the nasal septum to the opposite side and extended to the posterior wall of the maxilla. A biopsy specimen was obtained from the maxillary sinus through the inferior meatus. Histopathology identified polyhedral epithelial cells arranged in sheets and strands that exhibited nuclear pleomorphism and variable hyperchromasia without mitoses. There were numerous homogeneous, calcifiedbodies that were positive on Congo red staining. Based on these findings, a histopathologic diagnosis of CEOT was made.
Considering the extent and aggressive nature of the tumor, maxillectomy with orbital preservation was performed and the mass was excised (figure 4, A). The orbital floor was found to be eroded (figure 4, B),butthe periosteum was intact. The final histopathology result confirmed the initial diagnosis.
Postoperatively, a temporary palatal prosthesis was placed, and it was subsequently replaced with a permanent prosthesis. During 9 years offollow-up, the patient was asymptomatic and recurrence-free. CEOTs are preferentially located in the posterior region. The prevalence in the molar region is three times higher than that in the premolar region." CEOT with extension into the maxillary sinus is uncommon.'
The most common presentingcomplaint among affected patients is a painless, slowly growing expansile mass. Patients have occasionally reported nasal obstruction, headache, proptosis, and epistaxis." Although CEOT is a benign neoplasm, its biologic behavior is variable, ranging from very slight to moderately invasive. The tumor grows by infiltration, which can produce cortical expansion, tooth movement, and root resorption. Maxillary tumors might involve the sinus, but sinus symptoms are uncommon," Some 52% of maxillary
Discussion
CEOT affects the mandible twice as often as the maxilla, and it has a marked predilection for the premolar/molar/ramus area (82% of cases)," It is most commonly reported in patients during the fourth, fifth, and sixth decades of life; the mean age range is 33 to 43 years." It is usually not found in children and adolescents, and it has no predilection for either sex. ' Twotopographic variants ofCEOThave been identified: intraosseous and extraosseous. Intraosseous lesions-also called intrabony or central lesions-are far more common, occurring in 94% ofcases," Extraosseous lesions-also called peripheral or soft-tissue lesions-have a predilection for the anterior area of the jaw and involve the gingiva.3,6When presentin the maxilla, Figure 2 . Axial CTs demonstrate the radiopaque massin the rightmaxilla. CEOTs are associated with an unerupted tooth or buried tooth.' Local tissue infiltration had been documented. A few cases of malignant transformation and metastatic spread have been reported in the literature.S The specific epithelial cell from which CEOT originates remains unclear. Various explanations of origin have been proposed, including the basal cells of the oral epithelium, rests of the dental lamina, and the stratum interrnedium, as well as reduced enamel epithelium. Pindborg himself suggested that the tumor arises as a result of a reduction in enamel epithelium produced by the enamel organ because it is often associated with an embedded tooth.'
The occurrence of peripheral lesions suggests that CEOTs.arise from the basal cells of the oral epithelium or from remnants~f the dental lamina. The origin of clear cells also remains controversial; it might represent a degenerative process or it might be a feature of cytodifferentiation."
The radiologic features of CEOT are also variable.
Most lesions appear as an area of either diffuse or wellcircumscribed unilocular or multilocular radiolucency in a honeycomb pattern (snowstorm appearance). Multiple radiopacities of varying size with areas of calcification may also be evident.S When a tumor is associated with an unerupted tooth, the radiopacity tends to be located close to the tooth crown." The diagnosis of CEOT is based on histologic examination. CEOTs contain areas ofpolyhedral neoplastic cells as well as calcific, amyloid, or amyloid-like deposits." Microscopic analysis will reveal nests of closely packed polyhedral cells that frequently demonstrate nuclear pleomorphism. Mitoses are rare. An extracellular eosinophilic homogeneous material that stains similar to amyloid is characteristic of this tumor,' The eosinophilic material exhibits an apple-green birefringence under polarized light after staining with Congo red solution." Concentric calcified deposits (Liesegang rings) that resemble psammoma bodies are formed in the amyloid material. The nature of the amyloid-like material is unknown, but the material appears to derive from epithelial cells.'
The treatment of CEOT has ranged from simple enucleation or curettage to radical and extensive resection, such as hemimandibulectomy or hemimaxillectorny" The method of treatment depends on the size and anatomic location of the tumor," Pindborg did not recommend radical resection. Although CEOT is considered to be less aggressive clinically than are typical infiltrating ameloblastomas, treatment results have not been as satisfactoryas might be expected. Enucleation and curettage has been associated with a recurrence rate of 15 to 30% within 2 to 4 years and an overall rate of 14%.6 Lesions in the maxilla are more aggressive and require extensive procedures and are more likely to recur if not treated adequately," Resection with tumor free margin is the treatment of choice. We performed a maxillectomy in our case because the tumor represented a recurrence and because it involved the entire maxillary sinus and extended into the nasal cavity and anterior ethmoid sinuses.
A noncalcifying variant of Pindborg tumor has been reported." This very rare variant is aggressive and requires a more radical approach with long -term follow-up.
Despite some disappointing treatment results, the prognosis for patients with CEOT is good. As mentioned, malignant behavior is extremely rare.' Although the recommended length offollow-up has not been established in the literature, some authors have recommended that 5 years should be the absolute minimum necessary to assess the healing for this type of odontogenic tumor,"
